Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep:229:145-151.
doi: 10.1016/j.ajo.2021.03.064. Epub 2021 Apr 11.

Vision-Targeted Health-Related Quality-of-Life Survey for Evaluating Minimally Invasive Glaucoma Surgery

Qi N Cui  1 , Ron D Hays  2 , Michelle E Tarver  3 , George L Spaeth  4 , Sylvia H Paz  5 , Beverly Weidmer  6 , Ronald L Fellman  7 , Steven D Vold  8 , Malvina Eydelman  9 , Kuldev Singh  10
Affiliations
Review

Vision-Targeted Health-Related Quality-of-Life Survey for Evaluating Minimally Invasive Glaucoma Surgery

Qi N Cui et al. Am J Ophthalmol. 2021 Sep.

Abstract

Purpose: To develop a vision-targeted health-related quality-of-life instrument for patients with glaucoma who are candidates for minimally invasive glaucoma surgery (MIGS).

Design: Development of a health-related quality-of-life instrument.

Participants: Twelve practicing ophthalmologists and 41 glaucoma patients.

Methods: A questionnaire was constructed to assess functional limitations, vision-related symptoms, aesthetics, psychosocial issues, and surgical satisfaction for MIGS candidates. Questions were drafted after a review of the literature and subsequently refined based upon input from 1 physician and 4 patient focus groups. Nineteen cognitive interviews were used to ensure that questions were understandable to respondents.

Results: The focus group identified the following key issues and concerns as being important to glaucoma patients: functional limitations (eg, driving), bodily discomfort (eg, stinging from drops), changes in appearance (eg, drooping eyelid), and psychosocial concerns (eg, mental burden associated with a diagnosis of glaucoma, financial burden of treatment). Cognitive interviews resulted in the following improvements to the questionnaire: changes in wording to clarify lighting conditions, and additional questions addressing psychosocial issues, such as job loss, severity of disease, and perception of MIGS.

Conclusions: A patient-reported outcomes instrument, the Glaucoma Outcomes Survey, was developed to evaluate MIGS for patients with mild to moderate glaucoma. Next steps include electronic administration to patients selected from the American Academy of Ophthalmology Intelligent Research in Sight (IRIS) registry. An electronic patient-reported outcomes platform will be used to administer the questionnaire before and after MIGS. The questionnaire will improve understanding of how surgical interventions such as MIGS impact vision-targeted health-related quality-of-life in glaucoma patients.

PubMed Disclaimer

References

    1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–267. - PMC - PubMed
    1. Caprioli J, Kim JH, Friedman DS, et al. Special Commentary: Supporting Innovation for Safe and Effective Minimally Invasive Glaucoma Surgery: Summary of a Joint Meeting of the American Glaucoma Society and the Food and Drug Administration, Washington, DC, February 26, 2014. Ophthalmology. 2015;122(9):1795–1801. - PubMed
    1. U.S. Food and Drug Administration, Center for Devices and Radiological Health. Glaukos iStent® Trabecular Micro-Bypass Stent (Model: GTS-100R, GTS-100L) and Inserter (GTS-100i) - P090030, June 25, 2012. Accessed September 15, 2019. https://www.accessdata.fda.gov/cdrh_docs/pdf8/P080030a.pdf.
    1. U.S. Food and Drug Administration, Center for Devices and Radiological Health. Xen Glaucoma Treatment System - K161457, November 21, 2016. Accessed September 16, 2019. https://www.accessdata.fda.gov/cdrh_docs/pdf16/K161457.pdf.
    1. U.S. Food and Drug Administration, Center for Devices and Radiological Health. Hydrus® Microstent - P170034, August 10, 2018. Accessed September 16, 2019. https://www.accessdata.fda.gov/cdrh_docs/pdf17/P170034A.pdf.

Publication types